Global Blood Therapeutics, Inc. Increase (Decrease) in Prepaid Expense
Global Blood Therapeutics, Inc. reported Increase (Decrease) in Prepaid Expense of $2.50 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2019-02-27
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2016-12-31 was $277.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2016-09-30 was $69.00K, a 94.27% decline year-over-year.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2016-06-30 was -$270.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for the quarter ending 2016-03-31 was $685.00K.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2018 was $2.50M, a 34.70% increase from fiscal 2017.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2017 was $1.86M, a 143.89% increase from fiscal 2016.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2016 was $761.00K, a 774.71% increase from fiscal 2015.
- Global Blood Therapeutics, Inc. increase (decrease) in prepaid expense for fiscal 2015 was $87.00K, a 88.45% decline from fiscal 2014.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $2.50M 10-K · filed 2019-02-27 | |||
| 2017-12-31 | $1.86M 10-K · filed 2019-02-27 | |||
| 2016-12-31 | $277.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $346.00K derived: sum of 2 quarters · filed 2019-02-27 | $76.00K derived: sum of 3 quarters · filed 2019-02-27 | $761.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $69.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$201.00K derived: sum of 2 quarters · filed 2016-11-09 | $484.00K 10-Q · filed 2016-11-09 | $82.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | -$270.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | $415.00K 10-Q · filed 2016-08-10 | $13.00K derived: sum of 3 quarters · filed 2018-02-27 | $1.22M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $685.00K 10-Q · filed 2016-05-12 | $283.00K derived: sum of 2 quarters · filed 2018-02-27 | $1.49M derived: sum of 3 quarters · filed 2018-02-27 | $1.15M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$402.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $803.00K derived: sum of 2 quarters · filed 2018-02-27 | $465.00K derived: sum of 3 quarters · filed 2018-02-27 | $87.00K 10-K · filed 2018-02-27 |
| 2015-09-30 | $1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $867.00K derived: sum of 2 quarters · filed 2016-11-09 | $489.00K 10-Q · filed 2016-11-09 | $1.16M derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-06-30 | -$338.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$716.00K 10-Q · filed 2016-08-10 | -$50.00K derived: sum of 3 quarters · filed 2017-03-13 | -$49.00K derived: sum of 4 quarters · filed 2017-03-13 |
| 2015-03-31 | -$378.00K 10-Q · filed 2016-05-12 | $288.00K derived: sum of 2 quarters · filed 2017-03-13 | $289.00K derived: sum of 3 quarters · filed 2017-03-13 | |
| 2014-12-31 | $666.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $667.00K derived: sum of 2 quarters · filed 2017-03-13 | $753.00K 10-K · filed 2017-03-13 | |
| 2014-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $87.00K 10-Q · filed 2015-11-12 | ||
| 2014-06-30 | $86.00K 10-Q · filed 2015-09-24 | |||
| 2013-12-31 | $73.00K 10-K · filed 2016-03-29 |